Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Efficacy and safety of intravitreal and periocular injection of corticosteroids in noninfectious uveitis: a systematic review
Publication

Publications

Efficacy and safety of intravitreal and periocular injection of corticosteroids in noninfectious uveitis: a systematic review

Title
Efficacy and safety of intravitreal and periocular injection of corticosteroids in noninfectious uveitis: a systematic review
Type
Article in International Scientific Journal
Year
2022
Authors
Ferreira, A
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Meneres, P
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Figueira, L
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 67
Pages: 991-1013
ISSN: 0039-6257
Publisher: Elsevier
Other information
Authenticus ID: P-00V-SZT
Resumo (PT):
Abstract (EN): Uveitis is among the leading causes of visual loss in the working age population. In noninfectious uveitis, corticosteroids are the first line therapy. We sought to review systematically the evidence regarding the regional corticosteroid delivery modalities in the treatment of noninfectious uveitis. A 5-database search (Pubmed, ISI Web of Science, Cochrane, ClinicalTrials.gov, and Scopus) was performed from inception to February, 2021. Nineteen studies with a total of 1,935 eyes of 1,753 patients were selected from 8,922 abstracts retrieved by the initial search. The most frequently compared regimens were intravitreal triamcinolone acetonide injection and orbital floor triamcinolone acetonide injection (2 studies), intravitreal triamcinolone acetonide injection and posterior sub-Tenon triamcinolone acetonide injection (2 studies), and posterior sub-Tenon triamcinolone acetonide injection with the intravitreal dexamethasone implant (2 studies). Our results show that the intravitreal injec tion of corticosteroids is more effective, but is associated with more adverse events, than periocular injection. Some evidence supports the use of subconjunctival triamcinolone ace-tonide over intravitreal/periocular triamcinolone acetonide. Moreover, the overall results of 0.59 mg dosage of the intravitreal fluocinolone acetonide implant were superior to those from the 2.1 mg dose. The evidence, however, is not robust, and further studies with stan-dardized outcomes are warranted.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 23
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

The natural history of untreated ocular hypertension and glaucoma (2023)
Article in International Scientific Journal
Lauwers, A; Breda, JB; Stalmans, I
Serum vitamin D and age-related macular degeneration: Systematic review and meta-analysis (2021)
Article in International Scientific Journal
Ferreira, A; Silva, N; Furtado, MJ; Carneiro, A; Lume, M; Andrade, JP
Retinopathy of prematurity: A review of pathophysiology and signaling pathways (2023)
Article in International Scientific Journal
Fevereiro-Martins, M; Marques-Neves, C; Guimarães H; Bicho, M
Gut microbiota and age-related macular degeneration: A growing partnership (2022)
Article in International Scientific Journal
Lima-Fontes, M; Meira, L; Barata, P; Manuel Falcão; Ângela Carneiro
Detection of subclinical microvascular changes in systemic lupus erythematous using optical coherence tomography angiography: A systematic review and meta-analysis (2023)
Article in International Scientific Journal
Ferreira, A; Vieira, RJ; Furtado, MJ; Lume, M; Andrade, JP; Menéres, P
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-16 at 21:53:57 | Privacy Policy | Personal Data Protection Policy | Whistleblowing